Company: DVAX
Filing Date: 2025-04-03
Form Type: PREC14A
Source: 0000930413-25-001153
Chunk: 74

Company: DYNAVAX TECHNOLOGIES CORP
Filing Date: 2025-04-03
Form: PREC14A
Chunk 74
---
 of the NEOs vest over three years, with one-third vesting on the anniversary
of grant, and the remainder vesting monthly.

| 60 |

The table
below describes the stock options, RSUs and PSUs granted to our NEOs in fiscal year 2024. Our Compensation Committee used its subjective
judgement to determine the size of awards it believed were appropriate for each named executive officer, weighing the factors described
above each NEO’s current equity holdings and its desire to provide strong retentive value. Each of the 2024 equity awards
listed below were granted in February 2024.

| Name                 |     |         Stock 
 Option Awards 
 (

# of shares) |     | Time-Based RSU 
         Awards 
  (

# of shares) |     | Performance-Based 
        RSU Awards 
     (

# of shares) |
| Ryan Spencer         |     |       231,000 |     |        165,000 |     |           165,000 |
| Kelly MacDonald      |     |        65,000 |     |         46,430 |     |            46,430 |
| David F. Novack      |     |        95,000 |     |         67,860 |     |            67,860 |
| John L. Slebir       |     |        70,000 |     |         50,000 |     |            50,000 |
| Robert Janssen, M.D. |     |        50,000 |     |         35,710 |     |            35,710 |

Policies and Practices Related to the Grant of Certain Equity Awards Close in Time to the Release of Material Nonpublic Information

Our Compensation Committee approves all new-hire
equity awards for employees at the level of vice president and above, including our NEOs, other than our CEO. Our Compensation
Committee has separately authorized the Chief Executive Officer to approve new hire equity awards for all other employees below
the level of vice president based on pre-approved pools and ranges.

Annual awards and promotion awards are also
approved by the Compensation Committee for all employees, except our CEO. In the case of our CEO, our Compensation Committee makes
recommendations to the Board regarding CEO equity awards and the Board has final approval authority. The effective date of grant
is generally the date of the meeting, or the date the last committee member executes a unanimous written consent approving such
award.

Our Compensation Committee recommends